Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Nat Genet ; 38(3): 324-30, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16444273

ABSTRACT

Human earwax consists of wet and dry types. Dry earwax is frequent in East Asians, whereas wet earwax is common in other populations. Here we show that a SNP, 538G --> A (rs17822931), in the ABCC11 gene is responsible for determination of earwax type. The AA genotype corresponds to dry earwax, and GA and GG to wet type. A 27-bp deletion in ABCC11 exon 29 was also found in a few individuals of Asian ancestry. A functional assay demonstrated that cells with allele A show a lower excretory activity for cGMP than those with allele G. The allele A frequency shows a north-south and east-west downward geographical gradient; worldwide, it is highest in Chinese and Koreans, and a common dry-type haplotype is retained among various ethnic populations. These suggest that the allele A arose in northeast Asia and thereafter spread through the world. The 538G --> A SNP is the first example of DNA polymorphism determining a visible genetic trait.


Subject(s)
ATP-Binding Cassette Transporters/genetics , Cerumen/physiology , Polymorphism, Single Nucleotide , Case-Control Studies , Chromosome Mapping , Gene Frequency , Genetic Markers , Genotype , Humans , Molecular Sequence Data , Polymorphism, Genetic , Racial Groups/genetics
2.
Am J Hum Genet ; 84(3): 406-11, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19249007

ABSTRACT

Cleft lip with or without cleft palate (CL/P) is a complex trait with evidence that the clinical spectrum includes both microform and subepithelial lip defects. We identified missense and nonsense mutations in the BMP4 gene in 1 of 30 cases of microform clefts, 2 of 87 cases with subepithelial defects in the orbicularis oris muscle (OOM), 5 of 968 cases of overt CL/P, and 0 of 529 controls. These results provide confirmation that microforms and subepithelial OOM defects are part of the spectrum of CL/P and should be considered during clinical evaluation of families with clefts. Furthermore, we suggest a role for BMP4 in wound healing.


Subject(s)
Bone Morphogenetic Protein 4/genetics , Cleft Lip/genetics , Cleft Palate/genetics , Amino Acid Sequence , Bone Morphogenetic Protein 4/physiology , Child , Child, Preschool , Codon, Nonsense , Humans , Molecular Sequence Data , Mutation, Missense
3.
BMC Genet ; 10: 42, 2009 Aug 04.
Article in English | MEDLINE | ID: mdl-19650936

ABSTRACT

BACKGROUND: Two types of cerumen occur in humans: the wet type with brownish, sticky earwax, and the dry type with a lack of or reduced ceruminous secretion. The wet type is common in populations of European and African origin, while the dry type is frequently seen in Eastern Asian populations. An association between axillary odor and the wet-type earwax was first identified approximately 70 years ago. The data were based on a phenotypical analysis of the two phenotypes among the Japanese by a researcher or by self-declaration of the subjects examined, and were not obtained using definite diagnostic methods. Recently, we identified a single-nucleotide polymorphism (SNP; rs17822931) of the ABCC11 gene as the determinant of the earwax types. In the present study, to determine whether the SNP can serve as a diagnostic marker for axillary osmidrosis (AO), we examined genotypes at rs17822931 in 79 Japanese AO individuals. AO was defined here as a clinical condition of individuals with a deep anxiety regarding axillary odor and had undergone the removal of bilateral axillary apocrine glands. RESULTS: A comparison of the frequencies of genotypes at rs17822931 in the 79 AO individuals and in 161 Japanese from the general population showed that AO was strongly associated with the wet earwax genotype. A total of 78 (98.7%) of 79 AO patients had either the GG or GA genotype, while these genotypes were observed in 35.4% (57/161) of the subjects from the general population (p < 1.1 x 10(-24), by Fisher's exact test). CONCLUSION: The strong association between the wet-earwax associated ABCC11-genotypes (GG and GA) and AO identified in this study indicates that the genotypes are good markers for the diagnosis of AO. In addition, these results suggest that having the allele G is a prerequisite for the axillary odor expression. In other words, the ABCC11 protein may play a role in the excretory function of the axillary apocrine gland. Together, these results suggest that when an AO individual visiting a hospital is diagnosed with dry-type earwax by ABCC11-genotyping, surgical removal of their axillary glands may not be indicated.


Subject(s)
ATP-Binding Cassette Transporters/genetics , Axilla/physiopathology , Cerumen/metabolism , Gene Frequency , Sweat Gland Diseases/genetics , Asian People/genetics , Genotype , Humans , Phenotype , Polymorphism, Single Nucleotide
4.
Cancer Res ; 63(19): 6116-20, 2003 Oct 01.
Article in English | MEDLINE | ID: mdl-14559787

ABSTRACT

To search for potential molecular targets for development of novel anticancer drugs, we have been analyzing expression profiles of clinical samples from cancer patients, using a genome-wide cDNA microarray. In experiments with colon cancer cells, the gene encoding fibroblast growth factor 18 (FGF18) was among those that showed elevated expression. The promoter region of this gene was found to contain putative Tcf4-binding motifs; moreover a reporter-gene assay using luciferase activity as a marker and an electromobility shift assay indicated that FGF18 is a downstream transcription target in the beta-catenin/Tcf4 pathway. We showed that exogenous FGF18 promoted growth of NIH3T3 cells in an autocrine manner and that transfection of FGF18 short interfering RNAs suppressed growth of colon cancer cells in culture. Our results indicate that FGF18 is activated in colon cancers as a direct downstream target of the Wnt signaling pathway and that it might represent a marker for early diagnosis and a molecular target for treatment of this life-threatening tumor.


Subject(s)
Adenocarcinoma/genetics , Adenoma/genetics , Colorectal Neoplasms/genetics , Cytoskeletal Proteins/genetics , DNA-Binding Proteins/genetics , Fibroblast Growth Factors/genetics , Nerve Tissue Proteins , Trans-Activators/genetics , Transcription Factors/genetics , Adenocarcinoma/metabolism , Adenocarcinoma/pathology , Adenoma/metabolism , Adenoma/pathology , Animals , Basic Helix-Loop-Helix Leucine Zipper Transcription Factors , Binding Sites , Cell Division/physiology , Cell Line, Tumor , Colorectal Neoplasms/metabolism , Colorectal Neoplasms/pathology , Cytoskeletal Proteins/metabolism , DNA-Binding Proteins/metabolism , Fibroblast Growth Factors/biosynthesis , Gene Expression Regulation, Neoplastic , Humans , Mice , NIH 3T3 Cells , Plasmids/genetics , Promoter Regions, Genetic , RNA, Small Interfering/genetics , TCF Transcription Factors , Trans-Activators/metabolism , Transcription Factor 4 , Transcription Factor 7-Like 2 Protein , Transcription Factors/metabolism , Up-Regulation , beta Catenin
5.
Cancer Res ; 62(20): 5651-6, 2002 Oct 15.
Article in English | MEDLINE | ID: mdl-12384519

ABSTRACT

To clarify the molecular mechanisms of human carcinogenesis associated with abnormal beta-catenin/T-cell factor (Tcf) signaling, we have been using cDNA microarrays to search for genes whose expression is significantly altered after introduction of wild-type APC into SW480 colon cancer cells. These experiments identified a novel human gene, termed APCDD1, that was down-regulated in the cancer cells by exogenous wild-type APC; its expression was also reduced in response to transduction of AXIN1. Moreover, we documented elevated expression of APCDD1 in 18 of 27 primary colon cancer tissues compared with corresponding noncancerous mucosae. A reporter gene assay using the 5'-flanking region of APCDD1 indicated that transfection of beta-catenin together with wild-type Tcf4 into HeLa cells increased the reporter activity through two putative Tcf/lymphoid enhancer factor-binding motifs upstream of the transcription start site, indicating that APCDD1 is one of the direct targets of this transcription complex. Exogenous APCDD1 promoted growth of colon cancer cells both in vitro and in vivo, whereas transfection with antisense S-oligodeoxynucleotides decreased cell/tumor growth. These data suggest that APCDD1 is directly regulated by the beta-catenin/Tcf complex and that its elevated expression is likely to contribute to colorectal tumorigenesis.


Subject(s)
Colonic Neoplasms/genetics , Cytoskeletal Proteins/physiology , Trans-Activators/physiology , Transcription Factors/physiology , Cell Division/physiology , Colonic Neoplasms/metabolism , Colonic Neoplasms/pathology , Cytoskeletal Proteins/genetics , Cytoskeletal Proteins/metabolism , DNA, Complementary/genetics , DNA, Complementary/isolation & purification , Epithelial Cells/pathology , Gene Expression Regulation, Neoplastic , Genes, APC/physiology , HeLa Cells , Humans , Promoter Regions, Genetic , TCF Transcription Factors , Trans-Activators/genetics , Trans-Activators/metabolism , Transcription Factor 7-Like 2 Protein , Transcription Factors/genetics , Transcription Factors/metabolism , Tumor Cells, Cultured , beta Catenin
6.
Am J Med Genet ; 111(1): 38-42, 2002 Jul 22.
Article in English | MEDLINE | ID: mdl-12124731

ABSTRACT

We report a 20-year-old man with maternal uniparental disomy for chromosome 14 (UPD14) and maturity-onset diabetes mellitus (DM). He had pre- and postnatal growth retardation, developed DM at age 20 years without any autoimmune antibodies, and had a mosaic 45,XY,der(14;14)(q10;q10)[129]/46,XY,+14,der(14;14)(q10;q10)[1] karyotype. Allelotyping using microsatellite markers covering the entire 14q indicated segmental maternal isodisomy for 14q21-q24 and maternal heterodisomy of the remaining regions of the chromosome. It is thus tempting to speculate that the segmental isodisomy led to reduction to homozygosity for a mutant gene and thus caused his DM, although the possibility of coincidental occurrence of the two events cannot totally be ruled out. Fluorescence in situ hybridization (FISH) analysis using BAC clone probes revealed that the isodisomic segment did not overlap any known IDDM or NIDDM susceptibility loci on chromosome 14, suggesting a novel locus for a subset of DM at the isodisomic segment.


Subject(s)
Chromosomes, Human, Pair 14/genetics , Diabetes Mellitus, Type 2/genetics , Dwarfism/genetics , Intellectual Disability/genetics , Uniparental Disomy , Adult , Humans , Karyotyping , Male , Microsatellite Repeats , Mosaicism , Obesity/genetics , Phenotype
7.
J Hum Genet ; 53(1): 34-41, 2008.
Article in English | MEDLINE | ID: mdl-17987257

ABSTRACT

Hereditary congenital ptosis (PTOS) is defined as drooping of the upper eyelid without any other accompanying symptoms and distinguished from syndromic blepharoptosis. Two previous linkage analyses assigned a PTOS locus (PTOS1) to 1p32-p34.1 and another (PTOS2) to Xq24-q27.1. In addition, in a sporadic case with a balanced chromosomal translocation t(1;8) (p34.3;q21.12), the ZFHX4 (zinc finger homeodomain 4) gene was found to be disrupted at the 8q21.12 breakpoint, but there was no gene at the 1p34.3 breakpoint, suggesting the existence of the third PTOS locus (PTOS1) at 8q21.12. We carried out a genome-wide linkage analysis in a Japanese PTOS family and calculated two-point and multipoint log of odds (LOD) scores with reduced penetrance. Haplotype analysis gave three candidate disease-responsible regions, i.e., 8q21.11-q22.1, 12q24.32-q24.33, and 14q21.1-q23.2. Although the family size is too small to define one of them, 8q21.11-q22.1 is a likely candidate region, because it contains the previously reported translocation breakpoint above. We thus performed mutation, Southern-blot and methylation analyses of ZFHX4 but could not find any disease-specific change in the family. Nevertheless, our data may support the localization of PTOS1.


Subject(s)
Blepharoptosis/congenital , Blepharoptosis/genetics , DNA Mutational Analysis , Genetic Linkage , Family , Female , Genome, Human , Haplotypes , Humans , Japan , Male , Pedigree , Translocation, Genetic , Zinc Fingers/genetics
8.
Am J Med Genet A ; 143A(6): 546-52, 2007 Mar 15.
Article in English | MEDLINE | ID: mdl-17304554

ABSTRACT

Congenital arhinia, complete absence of the nose, is an extremely rare anomaly with unknown cause. To our knowledge, a total of 36 cases have been reported, but there has been no molecular-genetic study on this anomaly. We encountered a sporadic case of congenital arhinia associated with a de novo chromosomal translocation, t(3;12)(q13.2;p11.2). This led us to analyze the patient by BAC-based FISH for translocation breakpoints and whole-genome array CGH for other possible deletions/duplications in the genome. We found in this patient an approximately 19 Mb deletion spanning from 3q11.2 to 3q13.31 but no disruption of any gene(s) at the other breakpoint, 12p11.2. As the deleted segment at 3q was a strong candidate region containing the putative arhinia gene, we also performed the array CGH in four other arhinia patients with normal karyotypes, as well as mutation analysis of two genes, COL8A1 and CPOX, selected among hundreds of genes located to the deleted region, because they are expressed during early stages of human craniofacial development. However, in the four patients, there were no copy number aberrations in the region examined or no mutations in the two genes. Although our study failed to identify the putative arhinia gene, the data may become a clue to unravel the underlying mechanism of arhinia.


Subject(s)
Abnormalities, Multiple/genetics , Nose/abnormalities , Abnormalities, Multiple/pathology , Child, Preschool , Chromosome Aberrations , Chromosome Breakage , Chromosome Deletion , Chromosomes, Human, Pair 12 , Chromosomes, Human, Pair 3 , Collagen Type VIII/genetics , Coproporphyrinogen Oxidase/genetics , DNA Mutational Analysis , Female , Genome, Human , Humans , In Situ Hybridization, Fluorescence , Infant , Infant, Newborn , Karyotyping , Male , Nucleic Acid Hybridization/methods , Physical Chromosome Mapping
9.
Hum Genet ; 112(3): 220-6, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12552318

ABSTRACT

By a search for novel human imprinted genes in the vicinity of the imprinted gene MEST, at chromosome 7q32, we identified the carboxypeptidase A4 gene ( CPA4) in a gene cluster of the carboxypeptidase family, 200 kb centromeric to MEST. Because CPA4 was originally identified as a protein induced in a prostate cancer cell line (PC-3) by histone deacetylase inhibitors, and was located at the putative prostate cancer-aggressiveness locus at 7q32, we investigated its imprinting status in fetal tissues and in adult benign hypertrophic prostate (BPH). RT-PCR using four intragenic polymorphisms as markers showed that CPA4 was expressed preferentially from the maternal allele in the fetal heart, lung, liver, intestine, kidney, adrenal gland, and spleen, but not in the fetal brain. It was also preferentially expressed in the BPH. These findings support that CPA4 is imprinted and may become a strong candidate gene for prostate cancer-aggressiveness. As a Silver-Russell syndrome (SRS) locus has been proposed to be located to a region near MEST and to be involved in imprinting, CPA4 would have been a candidate gene for SRS. However, analysis of ten SRS patients revealed no mutations in CPA4.


Subject(s)
Biomarkers, Tumor/genetics , Carboxypeptidases/genetics , Chromosomes, Human, Pair 7/genetics , Genomic Imprinting , Prostatic Hyperplasia/genetics , Adrenal Glands/metabolism , Adult , Asian People/genetics , Brain/metabolism , Carboxypeptidases A , DNA Mutational Analysis , DNA, Complementary/analysis , Female , Fetus , Genotype , Humans , Intestinal Mucosa/metabolism , Japan , Kidney/metabolism , Lung/metabolism , Male , Mothers , Myocardium/metabolism , Prostatic Neoplasms/genetics , Proteins/genetics , Reverse Transcriptase Polymerase Chain Reaction , Spleen/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL